Medical device company AtriCure names a new president & CEO after posting its 3Q earnings, which came in below analysts' estimates.
AtriCure names Michael Carrel its new CEO
West Chester, Ohio-based device maker AtriCure (NSDQ:ATRC) named Michael Carrel as president, CEO and a member of the board of directors of the company, effective November 1.
Carrel will receive an annual base salary of $500,000, plus a $40,000 bonus and a year-end bonus of $62,500. He is also eligible for an annual performance bonus of up to 125% of his base salary, according to regulatory filings.
Carrel was previously president & CEO at Vital Images, which was acquired by Toshiba in 2011. Carrel held the role until 2012.
"Mike brings a solid track record of establishing strategic vision, expanding businesses internationally and driving revenue growth and subsequent profitability. We look forward to his leadership and contribution here at AtriCure," director Michael Hooven said during an earnings call with investors.
AtriCure also promoted Andrew Wade to principal accounting and financial officer.
Here's a look at some of the top funding stories for medical device companies this week.
FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine...
Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per...
California surgical devices maker Cardica details a public offering of common and preferred stock...